12:00 AM
May 21, 2012
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Cellerant preclinical data

In mice irradiated with lethal doses of radiation, IV allogenic mouse MP cells led to significant, dose-dependent improvements in survival when given up to 7 days post-irradiation vs. vehicle-treated controls. Furthermore, mouse MP cells mitigated death from ARS...

Read the full 169 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >